Core Insights - The 18th Health Industry Ecological Conference recognized Jichuan Pharmaceutical's products, Pudilan Xiaoyan Oral Liquid and Children's Chiqiao Qingre Granules (Tongbei), in the "2025 Healthy China Brand List" and "2025 Healthy China Brand Value List" for their outstanding quality and consumer trust [1] Group 1: Product Recognition - Pudilan Xiaoyan Oral Liquid is widely applicable for both children and adults, consistently ranking among the top brands in the market for heat-clearing and detoxifying traditional Chinese medicine [2] - The product has received numerous accolades, including "Highest Recommended Brand by Pharmacy Staff" and "Top 10 Best-Selling Drug Brands in Healthy China," reflecting its strong market presence and consumer approval [2] - Starting in 2024, Pudilan Xiaoyan Oral Liquid will be approved as a dual-category drug, allowing consumers to purchase it over-the-counter without a prescription, enhancing accessibility [2] Group 2: Children's Chiqiao Qingre Granules (Tongbei) - Children's Chiqiao Qingre Granules, based on the experience of renowned traditional Chinese medicine practitioner Professor Li Shaochuan, is a leading medication for children's colds [4] - The product has achieved high market share in urban public hospitals, retail pharmacies, and online platforms, earning multiple awards such as "Most Recommended Children's Medicine Brand" and "Top-Selling Brand in the Retail Drug Market" [5] - The recent approval of the syrup formulation of Children's Chiqiao Qingre Granules meets the differentiated medication needs of children, enhancing patient experience [5]